The researchers determined the GRACE risk score in 681 non-ST-elevation ACS patients enrolled in a treatment trial.
研究者检查了治疗实验中681名无st段抬高的急性冠脉综合征病人的GRACE危险分数。
Conclusion Detection of plasma BNP has prognosis value in the patients with non ST segment elevation ACS.
结论血浆BNP检测对无st段抬高的ACS患者预后有较好的判断价值。
Objective There have been many controversies on the value of percutaneous coronary intervention (PCI) in patients of non-ST-segment elevation ACS.
目的： 长期以来，介入治疗在非ST段抬高的急性冠脉综合症（ACS）患者的价值方面，意见不一。
Objective:To investigate the Xuefu Zhuyu Tang(XZT) treatment of non-ST segment elevation Acute Coronary Syndrome(NEST-ACS) and its impact on the effects of Inflammatory factors.
目的：探讨血府逐瘀汤治疗非ST段抬高型急性冠脉综合征（NEST-ACS）的临床疗效及其对炎症因子的影响。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
Objectives: the goal of this work was to explore the treatment and outcomes of patients with non-st-segment elevation acute coronary syndromes (NSTE-ACS) age 90 years.
目的：本研究旨在探讨90岁以上非st段抬高急性冠脉综合征(NSTE - ACS)患者的治疗措施及预后。
应用推荐